Invests in
Locations:
Min Investment:
$11,000,000.00Max Investment:
$65,000,000.00Target Investment:
$25,000,000.00
Skills
Education
- Uo
- IC
- BI
Lists including Philipp
Work Experience
2022
Vice President
2024
Board observer for: - Innovative Molecules - Ariceum Therapeutics - Hotspot Therapeutics - ATB Therapeutics
Associate
2022 - 2024
2021 - 2022
Analyst
2021 - 2022
Analyst at EQT Life Sciences (formerly LSP), part of the investment team focused on private companies and involved in all stages of the investment process.
2020 - 2021
Analyst
2020 - 2021
Fellow at M Ventures, the strategic corporate VC of Merck. Supporting the team in all aspects of the fund pipeline including scouting, deal flow, due diligence, portfolio company support, and exits.
2013 - 2014
Year in Research
2013 - 2014
Research in structural biology group, conducting research on intraflagellar trans- port proteins. Performed a full crystallographic research project from inception to publication, working together with a variety of team members to accomplish this in only nine months.
2012 - 2012
Intern
2012 - 2012
Summer internship focused on BBSome proteins in intraflagellar transport. Performed molecular cloning, expression and purification. Worked as an independent member of a small team.
2009 - 2009
Intern
2009 - 2009
Two week internship in a small biotech company focused on small molecule drug development and target discovery, involving mass spectrometry, mammalian tissue culture and analysis of mouse organ protein composition.